首页> 外国专利> RNA-3960 MicroRNA-3960 for diagnosing or predicting recurrence of colorectal cancer and use thereof

RNA-3960 MicroRNA-3960 for diagnosing or predicting recurrence of colorectal cancer and use thereof

机译:RNA-3960 MicroRNA-3960用于诊断或预测结直肠癌的复发及其用途

摘要

The present invention relates to a marker for diagnosing colorectal cancer or predicting prognosis of colorectal cancer and a use thereof and, more specifically, to a marker composition comprising microRNA-3960 (miR-3960) capable of diagnosing colorectal cancer or predicting prognosis of colorectal cancer patients, a composition and a kit for diagnosing colorectal cancer or predicting prognosis of colorectal cancer comprising an agent for measuring an expression level of the miR-3960, and a method for diagnosing colorectal cancer or predicting prognosis of colorectal cancer using the marker. The miR-3960 according to the present invention has significantly increased expression in colorectal cancer patients as compared to normal persons and significantly decreased expression after surgery as compared to before the patients undergo the surgery and thus, the miR-3960 is expected to be effectively used in clinic as a biomarker useful for both diagnosis of colorectal cancer and prediction of prognosis after treatment and surgery such as recurrence of diseases.
机译:本发明涉及诊断大肠癌或预测大肠癌预后的标志物及其用途,更具体地,涉及包含能够诊断大肠癌或预测大肠癌预后的microRNA-3960(miR-3960)的标志物组合物。患者,用于诊断结肠直肠癌或预测结肠直肠癌预后的组合物和试剂盒,包括用于测量miR-3960表达水平的试剂,以及用于使用该标记物诊断结肠直肠癌或预测结肠直肠癌预后的方法。与正常人相比,根据本发明的miR-3960在结直肠癌患者中的表达显着增加,并且与患者进行手术之前相比,在手术后的表达显着降低,因此,期望miR-3960被有效地使用。在临床上作为一种生物标志物,可用于大肠癌的诊断以及治疗和手术后疾病复发等预后的预测。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号